Your browser doesn't support javascript.
loading
The Metabolic Inhibitor CPI-613 Negates Treatment Enrichment of Ovarian Cancer Stem Cells.
Bellio, Chiara; DiGloria, Celeste; Spriggs, David R; Foster, Rosemary; Growdon, Whitfield B; Rueda, Bo R.
Afiliação
  • Bellio C; Vincent Center for Reproductive Biology, Department of Obstetrics and Gynecology, Massachusetts General Hospital, Boston, MA 02114, USA. chiarabellio87@gmail.com.
  • DiGloria C; Obstetrics, Gynecology and Reproductive Biology, Harvard Medical School, Boston, MA 02115, USA. chiarabellio87@gmail.com.
  • Spriggs DR; Vincent Center for Reproductive Biology, Department of Obstetrics and Gynecology, Massachusetts General Hospital, Boston, MA 02114, USA. CDIGLORIA@mgh.harvard.edu.
  • Foster R; Department of Medicine, Massachusetts General Hospital, Boston, MA 02114, USA. Dspriggs@mgh.harvard.edu.
  • Growdon WB; Department of Medicine, Harvard Medical School, Boston, MA 02115, USA. Dspriggs@mgh.harvard.edu.
  • Rueda BR; Vincent Center for Reproductive Biology, Department of Obstetrics and Gynecology, Massachusetts General Hospital, Boston, MA 02114, USA. RFOSTER1@mgh.harvard.edu.
Cancers (Basel) ; 11(11)2019 Oct 29.
Article em En | MEDLINE | ID: mdl-31671803
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Revista: Cancers (Basel) Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Revista: Cancers (Basel) Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Estados Unidos